617 filings
Page 14 of 31
8-K
78h 5jive6oc9pn3n
16 Oct 18
Other Events
1:18pm
8-K
23ccm2f3mj vgs
4 Oct 18
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek
6:01am
8-K
t3tzp
27 Sep 18
VBI Vaccines Announces Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
12:00am
8-K
e4a5gn01
17 Sep 18
Other Events
12:00am
8-K
t7g7l
4 Sep 18
VBI Vaccines to Present at the 20thAnnual Rodman & Renshaw Global Investment Conference
12:00am
8-K
a914rll
20 Aug 18
VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
12:00am
8-K
9qkf79c1 07h
6 Aug 18
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
4:29pm
EFFECT
ax4miea1bgypovwe
30 Jul 18
Notice of effectiveness
12:00am
8-K
6oe1uts wh4
26 Jul 18
VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update
7:49am
UPLOAD
i5ghvkvas hkob2rgot
26 Jul 18
Letter from SEC
12:00am
CORRESP
3dj8lbx2aefb0wj
26 Jul 18
Correspondence with SEC
12:00am
S-8
ym6rnvxf xkdjqm
20 Jul 18
Registration of securities for employees
4:07pm
8-K
e2c81nid9fk6 vs5
19 Jul 18
Entry into a Material Definitive Agreement
10:08am
8-K
qx48b
19 Jun 18
VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
8:59am
8-K
81ojb
6 Jun 18
Regulation FD Disclosure
4:15pm
8-K
f8edhnwf0w5
29 May 18
VBI Vaccines Announces Results of Annual General Meeting
10:59am
8-K
up3x76sifpodi
10 May 18
Regulation FD Disclosure
8:30am
8-K
r44ri6ax9mak5
1 May 18
VBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate Update
9:00am